Fagerberg E, Zetterstrõm O
Acta Allergol. 1975 Jul;30(2-3):63-72. doi: 10.1111/j.1398-9995.1975.tb01329.x.
In this investigation, a double-blind, cross-over trial of sodium cromoglycate in 23 patients with perennial rhinitis was carried out. An improvement in symptoms was found in actively-treated patients, and a greater preference was expressed for active treatment. There was no relationship between response to sodium cromoglycate and the results of allergological investigation. It is conclcuded that therapeutic trial of sodium cromoglycate is worth considering in patients with perennial rhinitis, irrespective of the results of RAST and intracutaneous skin tests.
在这项研究中，对23例常年性鼻炎患者进行了色甘酸钠双盲交叉试验。发现积极治疗的患者症状有所改善，且患者对积极治疗表现出更大的偏好。色甘酸钠的反应与变应性检查结果之间没有关联。得出的结论是，无论放射性变应原吸附试验（RAST）和皮内皮肤试验结果如何，色甘酸钠治疗试验在常年性鼻炎患者中值得考虑。
